Skip to main content
. 2021 Mar 29;23(12):1965–1978. doi: 10.1093/pm/pnaa468

Table 5.

Pain-Related Outcomes: Pre-post change (baseline to 2 months) and participant perceptions of change since baseline (n = 31)

Baseline mean (SD) Post-program (2 months) mean (SD) or n (%) P-value for pre-post change*
PROMIS-43 Pain Interference (6-item subscale): T-score (higher=worse; population mean = 50, SD = 10) 61.6 (5.5) 57.3 (7.2) P =.000
Pain Intensity (0 = no pain to 10 = worst you can imagine) 6.3 (2.4) 5.1 (2.4) P =.004
Pain Self-Efficacy (0 = least confidence to 6 = most confidence) 4.2 (1.3) 4.5 (1.1) P =.160
Global Impression of Change –Pain N/A N/A
  Much worse
  Worse 1 (3.2%)
  A little worse
  No change 3 (9.7%)
  A little better 13 (42.0%)
  Better 9 (29.0%)
  Much better 5 (16.1%)
Global Impression of Change –Functioning N/A N/A
  Much worse
  Worse
  A little worse
  No change 4 (13.0%)
  A little better 9 (29.0%)
  Better 10 (32.3%)
  Much better 9 (29.0%)
Global Impression of Change—Pain medication use N/A
  Taking much more
  Taking more
  Taking a little more 1 (3.2%)
  No change 15 (48.4%)
  Taking a little less 3 (9.7 %)
  Taking less 8 (25.8%)
  Taking much less 4 (12.9%)
*

Based on paired sample t-test.